OXISTAT Drug Patent Profile
✉ Email this page to a colleague
When do Oxistat patents expire, and when can generic versions of Oxistat launch?
Oxistat is a drug marketed by Fougera Pharms and Ani Pharms and is included in two NDAs.
The generic ingredient in OXISTAT is oxiconazole nitrate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxiconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxistat
A generic version of OXISTAT was approved as oxiconazole nitrate by TARO on March 7th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXISTAT?
- What are the global sales for OXISTAT?
- What is Average Wholesale Price for OXISTAT?
Summary for OXISTAT
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Clinical Trials: | 1 |
| Patent Applications: | 890 |
| Drug Prices: | Drug price information for OXISTAT |
| What excipients (inactive ingredients) are in OXISTAT? | OXISTAT excipients list |
| DailyMed Link: | OXISTAT at DailyMed |
Recent Clinical Trials for OXISTAT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Taro Pharmaceuticals USA | Phase 1 |
Pharmacology for OXISTAT
| Drug Class | Azole Antifungal |
US Patents and Regulatory Information for OXISTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | OXISTAT | oxiconazole nitrate | CREAM;TOPICAL | 019828-001 | Dec 30, 1988 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | OXISTAT | oxiconazole nitrate | LOTION;TOPICAL | 020209-001 | Sep 30, 1992 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
